ENANTA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 832 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 326-350 of 831 matching filings.

Per page
25
Current page
14
8-K File 001-35839

8-K HATA DIRECTOR

Filing date
23 Aug 2021
Reporting date
19 Aug 2021
Next action
Verify source filing
S-3ASR File 333-258632

S-3ASR

Filing date
09 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35839

Q3 2021 10-Q

Filing date
09 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-35839

8-K NATHALIE ADDA RETIREMENT

Filing date
16 Jul 2021
Reporting date
14 Jul 2021
Next action
Verify source filing
S-8 File 333-255957

S-8 2021

Filing date
10 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K Q2 2021 EARNINGS RELEASE

Filing date
06 May 2021
Reporting date
06 May 2021
Next action
Verify source filing
8-K File 001-35839

8-K PROXY VOTE

Filing date
05 Mar 2021
Reporting date
02 Mar 2021
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87373

SC 13G filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

AMENDMENT NO. 3

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87373

SC 13G filing

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SCHEDULE 13G/A

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87373

SC 13G filing

Filing date
09 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K ABBVIE 8.01 OTHER EVENTS

Filing date
05 Feb 2021
Reporting date
05 Feb 2021
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 001-35839

DEFR14A

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .